The Gastrointestinal Cancer Channel is supported with funding from Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2026 | Elucidating differences in immune landscapes between early and later onset CRC
José Perea, MD, PhD, European University of Madrid, Madrid, Spain, discusses the comparison between early onset and later onset colorectal cancer (CRC), highlighting the differences in immunological response between the two cohorts. Early onset colorectal cancer is characterized by a hyper-stimulated but inefficient immunological response, whereas later onset colorectal cancer is associated with immunoaging related to the age of the patients. This interview took place at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
